Supplement Facts
Virex Tablets
Dispensed by Prescription
Virex
- Manufacturer
- Trivia Pharmaceuticals, LLC
- Effective date
- 2026-04-16
- Label type
- DIETARY SUPPLEMENT
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:52:49
Label at a glance#
ProductVirex
Active ingredientLACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS DELBRUECKII BULGARICUS
Label structure7 sections
Label contents#
Full prescribing information#
Description:
Virex Probiotic Tablets are white, round tablets dispensed in plastic bottles of 50 ct.
84781-0112-50
Reserved for Professional Recommendation
Virex Probiotic Tablets should be administered under the supervision of a licensed medical practitioner.
Virex is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.
This listed product is not a National Drug Code, but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.
Manufactured for:
Trivia Pharmaceuticals
Gilbert, AZ
Warnings:
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients, including milk products.
Virex should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Dosage:
Usual dosage is 4 tablets 3 to 4 times daily, or as recommended by your healthcare professional.
Packaging:
CONTRAINDICATIONS
This product is contraindicated in patients with known hypersensitivity to any of the ingredients.
PRECAUTIONS
This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.
ADVERSE REACTIONS
Allergic sensitizations have been reported following oral administration of folic acid. Consult your physician immediately if adverse side effects occur.
KEEP OUT OF THE REACH OF CHILDREN.
Storage:
Store at 20° - 25° C (68° - 77° F); excursions permitted to 15°-30°C (59°-86°F) [See USP Controlled Room Temperature]
Packaging:
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 84781-112-50 | Virex | 50 in 1 BOTTLE | TABLET | 50 | 1 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 84781-112-50 | EA - Each | 84781-112 | ab037e2b-0da3-4710-a23b-884695ba8de9 | 1 | 2026-05-22 |
Products#
Every source-derived product name is available through these pages.
- Virex
- Lactobacillus Acidophilus
- LACTOBACILLUS DELBRUECKII BULGARICUS
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 84781-112 | 84781-112-50 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LACTOBACILLUS ACIDOPHILUS | 1PRR1V42V5 | ACTIB |
| LACTOBACILLUS DELBRUECKII BULGARICUS | HU1W4L947H | ACTIB |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Virex | ADENOVIREN NOSODE, ASCLEPIAS TUBEROSA, CALCAREA ARSENICICA, CAMPHORA, COXSACKIE A2 NOSODE, COXSACKIE A3 NOSODE, COXSACKIE A4 NOSODE, COXSACKIE A5 NOSODE, COXSACKIE A7 NOSODE, COXSACKIE B1 NOSODE, COXSACKIE B3 NOSODE, COXSACKIE B4 NOSODE, COXSACKIE B5 NOSODE, CYTOMEGALOVIRUS NOSODE, ECHINACEA PURPUREA, EPSTEIN-BARR VIRUS NOSODE, EUPHRASIA OFFICINALIS, INFLUENZINUM, LAC VACCINUM, MORBILLINUM, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, THUJA OCCIDENTALIS, TRIFOLIUM PRATENSE, VARIOLINUM | Nutritional Specialties, Inc. | 4baa5c95-79a6-4ae8-a8c4-1edbf308f92c | 2025-10-03 | Warnings | Virex |
| Virex | ASCLEPIAS TUBEROSA, ECHINACEA PURPUREA, TRIFOLIUM PRATENSE, NATRUM MURIATICUM, PHYTOLACCA DECANDRA, EUPHRASIA OFFICINALIS, LAC VACCINUM (NSPC), THUJA OCCIDENTALIS, CALCAREA ARSENICICA, CAMPHORA, INFLUENZINUM, CYTOMEGALOVIRUS NOSODE, MORBILLINUM, VARIOLINUM, COXSACKIE A2 NOSODE, COXSACKIE A3 NOSODE, COXSACKIE A4 NOSODE, COXSACKIE A7 NOSODE, COXSACKIE B1 NOSODE, COXSACKIE B3 NOSODE, COXSACKIE B5 NOSODE, COXSACKIE A5 NOSODE, ADENOVIREN NOSODE, EPSTEIN BARR VIRUS NOSODE, COXSACKIE B4 NOSODE | Nutritional Specialties, Inc. | a37728d6-2428-42f7-b331-c07cdc4e9956 | 2025-05-21 | Warnings | Virex |
| VIREX | ARSENICUM ALB, BAPTISIA, BELLADONNA, ECHINACEA, EUPATORIUM PERF, GELSEMIUM, LYCOPODIUM, , NUX VOM, PHOSPHORICUM AC, PHOSPHORUS, PYROGENIUM, RHUS TOX | White Manufacturing Inc. DBA Micro-West | 77b9e94e-e159-4b77-bd8a-9f5937ac2906 | 2022-12-02 | Warnings | VIREX |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.